Sign up for free insights newsletter
Shinpoong Pharmaceutical Co Ltd

Shinpoong Pharmaceutical Co Ltd

019175KO

Need professional-grade analysis? Visit stockanalysis.com

₩15,800.00
+0.77%
End of day
Market Cap

$803.28B

P/E Ratio

91.02

Employees

809

Dividend Yield

N/A

Price Chart

Risk-Adjusted Performance

Ratio1W1M3M6M1Y5YScore
Sortino14.00-1.89-1.63-1.490.83-0.610.02
Calmar-4.33-2.35-1.160.56-0.32-1.01
Sharpe5.68-1.56-1.25-1.060.39-0.33-0.26
Omega2.280.670.650.771.191.000.98
Martin-7.60-4.21-2.100.83-0.39-1.79
Ulcer0.355.4016.7125.7445.6074.8838.33

Shinpoong Pharmaceutical Co Ltd (019175) Price Performance

Shinpoong Pharmaceutical Co Ltd (019175) trades on KO in KRW. The company is classified in the Healthcare sector under the Drug Manufacturers - Specialty & Generic industry. The stock currently trades at KRW15800.00, up 0.77% from the previous close.

Over the past year, 019175 has traded between a low of KRW11430.00 and a high of KRW46450.00. The stock has gained 37.8% over this period. It is currently 66.0% below its 52-week high.

Shinpoong Pharmaceutical Co Ltd has a market capitalization of $803.28B, with a price-to-earnings ratio of 91.02.

About Shinpoong Pharmaceutical Co Ltd

Shinpoong Pharmaceutical Co.,Ltd, together with its subsidiaries, manufactures and sells pharmaceutical products in South Korea. The company offers cephalosporin antibiotics; penicillin antibiotics; and finished products, as well as antivirals, anticancer drugs, painkillers, anti-inflammatory products, and anthelmintics. It provides active pharmaceutical ingredients; Pyramax, an anti-malarial drug; and drugs for treating hypercholesterolemia, knee osteoarthritis and shoulder periarthritis, and surgical adhesion barrier; prescription drugs; wound dressings; health functional food; and over the counter products. In addition, the company engages in business management and exports its products to approximately 50 countries. The company was founded in 1962 and is headquartered in Seoul, South Korea.

Company Info

Exchange
KO
Currency
KRW

Financial Metrics

Revenue (TTM)
$234.68B
EBITDA
$25.65B
Profit Margin
3.76%
EPS (TTM)
N/A
Book Value
269975.00

Technical Indicators

52 Week High
₩55,000.00
52 Week Low
₩10,850.00
50 Day MA
₩18,198.40
200 Day MA
₩23,335.60
Beta
1.27

Valuation

Trailing P/E
91.02
Forward P/E
N/A
Price/Sales
3.42
Price/Book
2.95
Enterprise Value
$779.50B